Thirusha Lane

7.7k total citations · 1 hit paper
66 papers, 2.8k citations indexed

About

Thirusha Lane is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Thirusha Lane has authored 66 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 24 papers in Nephrology and 14 papers in Epidemiology. Recurrent topics in Thirusha Lane's work include Amyloidosis: Diagnosis, Treatment, Outcomes (45 papers), Parathyroid Disorders and Treatments (18 papers) and Inflammasome and immune disorders (14 papers). Thirusha Lane is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (45 papers), Parathyroid Disorders and Treatments (18 papers) and Inflammasome and immune disorders (14 papers). Thirusha Lane collaborates with scholars based in United Kingdom, United States and Germany. Thirusha Lane's co-authors include Philip N. Hawkins, Julian D. Gillmore, Helen J. Lachmann, Ashutosh Wechalekar, Carol Whelan, Marianna Fontana, Dorota Rowczenio, Janet A. Gilbertson, Darren Foard and Lisa Rannigan and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Thirusha Lane

64 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new staging system for cardiac transthyretin amyloidosis

2017 453 citations Julian D. Gillmore, Marianna Fontana et al. profile →

Peers

Thirusha Lane

NEPHR

ONCOL

GENET

RHEUM

Dorota Rowczenio United Kingdom

Christopher P. Venner Canada

A Bybee United Kingdom

Costanza Sagrinati Italy

Orso Maria Lucherini Italy

RA Kyle United States

Emmanuelle Plaisier France

Minke G. Huitema Netherlands

Yasufumi Masaki Japan

Abraham Rutgers Netherlands

Dorota Rowczenio United Kingdom

Thirusha Lane

3.3k ×1.4

1.3k ×1.6

NEPHR

687 ×1.3

ONCOL

267 ×0.6

GENET

670 ×1.6

RHEUM

Citations per year, relative to Thirusha Lane Thirusha Lane (= 1×) peers Dorota Rowczenio

Countries citing papers authored by Thirusha Lane

Since Specialization

Citations

This map shows the geographic impact of Thirusha Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thirusha Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thirusha Lane more than expected).

Fields of papers citing papers by Thirusha Lane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thirusha Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thirusha Lane. The network helps show where Thirusha Lane may publish in the future.

Co-authorship network of co-authors of Thirusha Lane

This figure shows the co-authorship network connecting the top 25 collaborators of Thirusha Lane. A scholar is included among the top collaborators of Thirusha Lane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thirusha Lane. Thirusha Lane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Obici, Laura, Teofila Bueser, Isabel Conceição, et al.. (2023). Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals. BMJ Open. 13(9). e073130–e073130. 4 indexed citations

Fontana, Marianna, Ana Martinez–Naharro, Liza Chacko, et al.. (2020). Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression. JACC. Cardiovascular imaging. 14(1). 189–199. 128 indexed citations

Rezk, Tamer, Helen J. Lachmann, Marianna Fontana, et al.. (2019). Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers. British Journal of Haematology. 186(3). 460–470. 15 indexed citations

Rezk, Tamer, Andrew Davenport, Helen J. Lachmann, et al.. (2018). Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis. British Journal of Haematology. 185(5). 977–980. 4 indexed citations

Youngstein, Taryn, Patrycja Hoffmann, Ahmet Gül, et al.. (2017). International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Lara D. Veeken. 56(12). 2102–2108. 88 indexed citations

Manwani, Richa, Darren Foard, Shameem Mahmood, et al.. (2017). Prolonged Progression Free Survival and Time to Next Treatment Are Achievable Outcomes in Patients with Systemic AL Amyloidosis Treated with Novel Agent Chemotherapy: Analysis of the Alchemy Study. Blood. 130. 1816–1816. 1 indexed citations

Lane, Thirusha & Helen J. Lachmann. (2017). Reply to: Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis. Dinoia et al.. PubMed. 35(1). 171–171. 9 indexed citations

Rowczenio, Dorota, Sónia Gomes, Juan I. Aróstegui, et al.. (2017). Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience. Frontiers in Immunology. 8. 1410–1410. 95 indexed citations

Lane, Thirusha, Julian D. Gillmore, Ashutosh Wechalekar, Philip N. Hawkins, & Helen J. Lachmann. (2016). Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.. PubMed. 33(6 Suppl 94). S46–53. 37 indexed citations

10.

Martinez–Naharro, Ana, Amna Abdel‐Gadir, Thomas A. Treibel, et al.. (2016). Abstract 14407: Regression of Cardiac AL Amyloid by Cardiovascular Magnetic Resonance. Circulation. 134. 2 indexed citations

11.

Rowczenio, Dorota, Daniela Iancu, Hadija Trojer, et al.. (2016). Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue—a case series and genetic exploration. Lara D. Veeken. 56(2). 209–213. 43 indexed citations

12.

Mahmood, Shameem, Sajitha Sachchithanantham, Thirusha Lane, et al.. (2016). Comparison of Free Light Chain Assays. American Journal of Clinical Pathology. 146(1). 78–85. 7 indexed citations

13.

Richards, Duncan, Louise Cookson, Aliénor Berges, et al.. (2015). Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. New England Journal of Medicine. 373(12). 1106–1114. 261 indexed citations

14.

Mahmood, Shameem, Leena George, Milind Sovani, et al.. (2014). High prevalence of sleep disordered breathing (SDB) in patients with systemic AL amyloidosis. European Respiratory Journal. 44(Suppl 58). P4928–P4928. 1 indexed citations

15.

Hutt, David F., Joanne Page, Margaret Hall, et al.. (2014). Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. European Heart Journal - Cardiovascular Imaging. 15(11). 1289–1298. 158 indexed citations

16.

Venner, Christopher P., Julian D. Gillmore, Sajitha Sachchithanantham, et al.. (2014). A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis. Leukemia. 28(12). 2304–2310. 64 indexed citations

17.

Venner, Christopher P., Thirusha Lane, Darren Foard, et al.. (2012). Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival. Blood. 119(19). 4387–4390. 197 indexed citations

18.

Dickie, Laura, Sinisa Savic, Orso Maria Lucherini, et al.. (2012). Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Annals of the Rheumatic Diseases. 71(12). 2035–2043. 58 indexed citations

19.

Gillmore, JD, Helen J. Lachmann, Thirusha Lane, et al.. (2010). CTD versus Mel-Dex as upfront treatment in AL amyloidosis: a matched case-control study. UCL Discovery (University College London). 3 indexed citations

20.

Whelan, CJ, Babita Pawarova, Thirusha Lane, et al.. (2010). Rise in serum NT pro-BNP associated with chemotherapy in patients with AL amyloidosis: implications for organ response assessment. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact